CNBC’s Kate Rooney sits down with Pat Grady, Sequoia Capital partner, and Daniel Nadler, OpenEvidence CEO and founder, to discuss the potential of OpenEvidence, an AI co-pilot that assists medical professionals with navigating high-stakes clinical decisions.
